Xcelerating Life Sciences Fireside Chat
Teresa Lavoie, principal at Fish & Richardson, speaks with Xconomy Managing Editor Dan Stanton about the legal complications of using machine learning and AI in discovering small molecule and biologic drugs, and how the patent landscape is likely to evolve.
Sponsored · Whitepaper
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders
Sponsored · Whitepaper
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
PRA Health Sciences
Sponsored · Whitepaper
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
IBM Watson
